Skip directly to Accessibility Notice

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 03/05/21

  • 30-Day SEC Yield1

    1.60%
  • Total Net Assets

    $183.6M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.42%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Quarterly

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    2,738,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.07%
  • Gross Expense Ratio

    0.42%
  • Fee Waivers and
    Expense Reimbursement

    -0.07%
  • Net Expense Ratio/TER2

    0.35%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2022. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Investment Professionals

  • Portfolio Manager and Head of Equity ETFs
  • Oversees the Equity ETF Investment Management Team including development and management of index replication and optimization strategies
  • Joined VanEck in 2005
  • CFA charterholder; member of the CFA Society New York
  • BA, Mathematics and Economics, New York University
  • Portfolio Manager and Analyst for Equity ETFs
  • Joined VanEck in 2007
  • Prior to his current role, held a portfolio administration position at VanEck
  • Previously, Portfolio Analyst at Evaluation Associates
  • BS, Business Administration (concentration in Financial Analysis), State University of New York at Buffalo
  • Analyst for Equity ETFs
  • Joined VanEck in 2018
  • Prior to joining VanEck, ETF Basket Operations Analyst at JPMorgan
  • BS, Finance, Providence College
  • Analyst for Equity ETFs
  • Joined VanEck in 2019
  • Prior to VanEck, Intermediate Representative, Exchange Traded Funds at BNY Mellon.
  • BS, Accounting, Hunter College

Prices as of 03/05/21

NAV/
Market Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
30-Day
Median
Bid Ask
Spread
NAV
Chart
PPH $67.07
$67.14
63,908
159,027
$1.02 / +1.54%
$1.08 / +1.63%
+1.34%
+1.41%
$0.07
0.10%
0.04%

Premium/Discount History as of 03/05/21

Calendar Year 2019 1Q 2020 2Q 2020 3Q 2020 4Q 2020 Premium/Discount Charts NAV & Prem/Discount History
Days closed at a premium 88 22 32 29 41
PPH Days closed at NAV 22 5 3 8 1
Days closed at a discount 142 35 28 27 22

Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) -1.01 4.06 1.87 16.19 7.24 5.32 -- 9.31
PPH (Share Price) -0.90 4.24 2.00 16.46 7.29 5.34 -- 9.45
MVPPHTR (Index) -1.03 3.97 1.44 15.84 7.03 5.22 -- 9.22
Performance Differential (NAV - Index) 0.02 0.09 0.43 0.35 0.21 0.10 -- 0.09
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 2.15 7.47 5.20 5.20 5.74 2.33 -- 9.26
PPH (Share Price) 2.20 7.35 5.33 5.33 5.77 2.32 -- 9.38
MVPPHTR (Index) 2.49 7.80 4.96 4.96 5.60 2.26 -- 9.22
Performance Differential (NAV - Index) -0.34 -0.33 0.24 0.24 0.14 0.07 -- 0.04

Top 10 Holdings (%) as of 02/28/21 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
ELI LILLY AND CO
LLY US
56,332
11,541,863 6.49
CATALENT INC
CTLT US
86,778
9,867,526 5.55
JOHNSON & JOHNSON
JNJ US
58,136
9,212,231 5.18
BRISTOL-MYERS SQUIBB CO
BMY US
146,104
8,960,558 5.04
ABBVIE INC
ABBV US
81,908
8,824,768 4.96
NOVARTIS AG
NVS US
97,159
8,346,930 4.69
SANOFI
SNY US
179,414
8,233,308 4.63
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA US
752,173
8,093,381 4.55
BAUSCH HEALTH COS INC
BHC US
257,389
8,087,162 4.55
AMERISOURCEBERGEN CORP
ABC US
79,226
8,019,256 4.51
Top 10 Total (%) 50.15
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 02/28/21

  • Country

    % of Net Assets
  • United States

    66.68
  • United Kingdom

    10.28
  • Switzerland

    4.69
  • France

    4.63
  • Israel

    4.55
  • Japan

    4.03
  • Denmark

    3.95
  • Ireland

    1.28
  • Other/Cash

    -0.09

Sector Weightings (%) as of 02/28/21

  • Sector

    % of Net Assets
  • Health Care

    100.1
  • Other/Cash

    -0.1